| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Mecp2 and associated rett syndrome 0.6478056404738141 2.6960460603738654 0.007016796329595 0.9851660206541548 0.669759672978262 22 Q03518,Q00013,Q05086,Q96ST3,P31943,P67809,P52597,P35637 8 |
| Oxidation by cytochrome p450 0.8809564722434314 2.421538343337043 0.0154549704990543 0.9999098679566246 0.669759672978262 6 Q6UW02,Q16850,O43169 3 |
| Electron transport chain oxphos system in mitochondria 0.493291849156483 2.4024466033878182 0.0162858119835747 0.9999455969481588 0.669759672978262 46 P06576,P22695,P20674,O75880,O43676,Q9Y6M9,P56556,Q9UDW1,O14949,O75964,P12235,O96000,P13073,P56134 14 |
| Angiopoietinlike protein 8 regulatory pathway 0.5558649948744976 2.2470006124565436 0.0246399879690999 0.9999996683821388 0.669759672978262 31 Q9Y478,Q15418,P31751,P51812,P41440 5 |
| Vitamin a and carotenoid metabolism 0.8872590930540682 2.217536429373936 0.0265864565174798 0.9999998995763724 0.6880022016400443 5 O94788 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.747111101734415 2.1951545932865644 0.0281525101766679 0.9999999616580564 0.6880022016400443 12 O15460,Q32P28,O75718,Q96AY3 4 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.8000271156442672 2.131422786522296 0.0330543272972876 0.9999999981360238 0.6880022016400443 7 Q15418 1 |
| Striated muscle contraction pathway 0.8084112149532867 2.1177851882597305 0.0341932643100619 0.9999999990787924 0.6880022016400443 6 P28289,P06753,P67936,P08670,P09493 5 |
| Metabolism of spingolipids in er and golgi apparatus 0.8503037495263033 2.0692349069527234 0.0385240485588886 0.9999999999373128 0.6880022016400443 5 Q06136 1 |
| Ethanol effects on histone modifications 0.7165659158385368 2.044952752718621 0.0408595163538418 0.999999999985359 0.6880022016400443 12 O94788,P41440 2 |
| Endometrial cancer 0.6793480340641311 1.9275523126361045 0.0539108352671118 0.999999999999996 0.6880022016400443 13 O00459,P31751,Q9UJX6 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7625046468935284 1.9200791980607137 0.0548478964138583 0.9999999999999978 0.6880022016400443 6 Q16850,Q15392,Q9UBM7 3 |
| Insulin signaling 0.465600228485175 1.8673251352362463 0.061856197396664 1.0 0.6880022016400443 41 O00459,Q15418,P31751,P51812,P41440 5 |
| Familial partial lipodystrophy fpld 0.7284163441864252 1.8630286326459589 0.0624582379271694 1.0 0.6880022016400443 8 P02545,O60725,Q03252,P31751 4 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.8468428021460357 1.8448888315024672 0.0650537116534062 1.0 0.6880022016400443 4 P08670 1 |
| 1q211 copy number variation syndrome 0.6943698473856497 1.810286347450556 0.0702513931187636 1.0 0.7165168947997862 10 Q9NPH0 1 |
| Heme biosynthesis 0.8361497543789822 1.80305241206286 0.0713799837911577 1.0 0.7165168947997862 4 P50336 1 |
| Nonalcoholic fatty liver disease 0.4086446358075878 1.652804487623008 0.0983706604844185 1.0 0.7525215633937993 52 Q9Y478,P22695,P20674,O43676,O00459,Q9Y6M9,P56556,Q9UDW1,O14949,P49841,P31751,O96000,Q86Y39,P13073 14 |
| Progeriaassociated lipodystrophy 0.6456879591809966 1.627696893210361 0.1035891721995727 1.0 0.7525215633937993 11 Q03252,O60725,P09874,Q14191,P02545 5 |
| Nanomaterial induced apoptosis 0.6869952402401107 1.6270777995195822 0.1037205754057182 1.0 0.7525215633937993 7 Q9NR28,O95831 2 |
| Metapathway biotransformation phase i and ii 0.4893778023363606 1.6236666476933563 0.1044469728456276 1.0 0.7525215633937993 23 Q16850,P21964,Q6UW02,Q8NCH0,P00390 5 |
| Neural crest differentiation 0.6741812473542091 1.612102006524949 0.1069397441893067 1.0 0.7613091312524457 8 Q9NR77,P19022 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7334474261365556 1.5857645079883655 0.112792739665442 1.0 0.7626821685817241 5 O60725,P02545 2 |
| Vitamin dsensitive calcium signaling in depression 0.677561250111206 1.5839206121092022 0.1132117861390495 1.0 0.7626821685817241 7 P00390 1 |
| Photodynamic therapyinduced unfolded protein response 0.6465259106923399 1.5773115152922943 0.1147238640571526 1.0 0.7626821685817241 10 P14625,P08243,Q9UBS4,Q13217 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4806497259947767 1.5676766700893718 0.1169566089977809 1.0 0.7685720019854175 24 Q16850,P48449,Q15392 3 |
| Integrinmediated cell adhesion 0.4721397898138249 1.5134630442941828 0.130162081489259 1.0 0.8193360497955462 25 P31751,Q14185 2 |
| Ccl18 signaling pathway 0.6392999436193918 1.4926871240298225 0.1355191053767852 1.0 0.8239205846521401 9 P08670,P07196,P33176,P19022 4 |
| Omega3 omega6 fatty acid synthesis 0.6634309889762458 1.4802560820744557 0.1388049188375193 1.0 0.8239205846521401 6 P33121,O15254,Q15067 3 |
| Apoptosis modulation and signaling 0.56631646672588 1.4586250681991852 0.1446683300810614 1.0 0.8239205846521401 15 Q9NR28,Q07820,O95831 3 |
| Translation inhibitors in chronically activated pdgfra cells 0.494035571238054 1.4316865887054506 0.1522335362661535 1.0 0.8508005110949516 20 Q15418,P31751 2 |
| Oxidative stress response 0.6958831447217636 1.426519618674274 0.1537184080320628 1.0 0.8511445185479035 5 P00390 1 |
| Proteoglycan biosynthesis 0.6487154950790802 1.4136766127551248 0.1574568752105407 1.0 0.8563028494522511 6 Q96L58,Q93063,Q8NCH0 3 |
| Orexin receptor pathway 0.5565004278596415 1.4028658885886265 0.1606568345310659 1.0 0.8563028494522511 15 P31350,O00459,O60313,P50336,Q8TDW0 5 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6316809291953622 1.3722514322211383 0.169985179300268 1.0 0.8744247457118589 7 Q9BXK5,Q07820 2 |
| Chromosomal and microsatellite instability in colorectal cancer 0.5122568740371597 1.3675918083146994 0.1714398820088303 1.0 0.8744247457118589 18 Q9UJX6,P31751 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6040826484345974 1.3673066602316934 0.1715292049701944 1.0 0.8744247457118589 10 Q9UI14,O60333,Q9NR77,P07196 4 |
| Folate metabolism 0.5724198170071457 1.3629765389266042 0.1728899047144341 1.0 0.8744247457118589 13 P00374,Q8WTV0,P41440 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.719996544566167 1.3411845795078945 0.1798605317391057 1.0 0.8812200620115174 4 P31751 1 |
| Kit receptor signaling pathway 0.5178755048851011 1.3218023141831332 0.1862339875421257 1.0 0.8909433964015294 17 Q15418,P51812 2 |
| Selenium micronutrient network 0.5907086656704453 1.300669892398321 0.1933714720985695 1.0 0.8938559569414305 10 P00390,Q8NFF5,Q8WTV0 3 |
| Nad biosynthetic pathways 0.665929874422053 1.2987483345903736 0.1940303105469931 1.0 0.8938559569414305 5 Q8IXJ6,Q9UGN5 2 |
| Sulfation biotransformation reaction 0.8223463600738482 1.2879611589491318 0.1977594841190173 1.0 0.8938559569414305 3 P00390 1 |
| T cell receptor and costimulatory signaling 0.6079746754047921 1.2620207084951394 0.2069413348606428 1.0 0.8938559569414305 7 Q15118,P49841,Q08209 3 |
| Vitamin b12 metabolism 0.6122280118090825 1.2477299092633864 0.2121299842868467 1.0 0.8938559569414305 6 Q8WTV0 1 |
| Sphingolipid metabolism integrated pathway 0.5854700135323369 1.2312724861147923 0.2182209687515839 1.0 0.8938559569414305 9 Q96G23,Q06136 2 |
| Sphingolipid metabolism overview 0.5854700135323369 1.2312724861147923 0.2182209687515839 1.0 0.8938559569414305 9 Q96G23,Q06136 2 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.5811256929171864 1.210078888541631 0.2262486231971028 1.0 0.8938559569414305 9 Q9Y478,P49770,Q15118,P49841,P06730,P42345 6 |
| 15q112 copy number variation syndrome 0.6863974039158374 1.2062798794605576 0.2277095930184898 1.0 0.8938559569414305 4 Q7L576,Q9BSJ2 2 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6438300722406037 1.2042778513010963 0.2284822043962675 1.0 0.8938559569414305 5 P06753,P06730 2 |
| Ketogenesis and ketolysis 0.6026236426121016 1.2039238832332972 0.2286189997315144 1.0 0.8938559569414305 6 P23786,P35610,O43772 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.5324148873972804 1.2032476981262483 0.2288804819135608 1.0 0.8938559569414305 14 Q9Y478,P31751,O00459,Q05086 4 |
| Mitochondrial complex iii assembly 0.5702073346924373 1.1982734797812944 0.2308105675025062 1.0 0.8938559569414305 10 P22695,Q9Y276,Q9UDW1,O14949,Q6DKK2 5 |
| Regulation of sister chromatid separation at the metaphaseanaphase transition 0.5655138073918621 1.133892378918718 0.2568396943026989 1.0 0.8938559569414305 9 Q9UJX6 1 |
| Oxidative phosphorylation 0.4187684600137433 1.1262279077641817 0.2600690636729357 1.0 0.8938559569414305 27 P06576,Q9Y6M9,P56556,O75964,P56385,O96000,Q86Y39,P56134 8 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4059900093252977 1.1217093587556246 0.2619860360482366 1.0 0.8938559569414305 34 Q16850,P48449,Q9HCL2,Q8WTV0 4 |
| Riboflavin and coq disorders 0.6637815485970013 1.1156560143729877 0.2645694053154401 1.0 0.8938559569414305 4 Q8NFF5 1 |
| Small cell lung cancer 0.5156810692648983 1.1101846642495348 0.2669194598014091 1.0 0.8953925226311883 14 P31751 1 |
| Neuroinflammation 0.6165299091412597 1.087689630339117 0.2767321470769692 1.0 0.9011846161722232 5 Q8N9N2 1 |
| Erbb signaling pathway 0.4771206418185391 1.0734995328936614 0.2830470481330198 1.0 0.9064541849145727 17 O00459,P49841,P12931,P31751 4 |
| Il5 signaling pathway 0.5077307674745254 1.065990996112106 0.2864277121055241 1.0 0.9064541849145727 14 O00459,Q15418 2 |
| Cholesterol biosynthesis pathway 0.5141778797481553 1.048462449160657 0.2944255943654017 1.0 0.9064541849145727 13 Q16850,P48449 2 |
| Thermogenesis 0.4047011004253458 1.0355052533520157 0.3004330143459781 1.0 0.9064541849145727 29 Q15418,P51812,O43772 3 |
| Sphingolipid pathway 0.5364474455554331 1.0295982424653911 0.3031986406447289 1.0 0.9064541849145727 10 Q96G23,Q06136 2 |
| Development of ureteric collection system 0.6392272909537606 1.017758809041001 0.308792591675145 1.0 0.9064541849145727 4 P05556,Q12948 2 |
| B cell receptor signaling pathway 0.4313076652304421 1.0078416326466322 0.3135304957156646 1.0 0.9064541849145727 20 O00459,Q15418 2 |
| Mitochondrial gene expression 0.5955698394219757 0.9985535367526326 0.3180110176473314 1.0 0.9101555510149072 5 Q9P2K5,O00411 2 |
| Nad metabolism 0.6343421056293764 0.9983743988191374 0.3180978430804608 1.0 0.9101555510149072 4 Q8IXJ6 1 |
| S1p receptor signal transduction 0.5342323858078162 0.981533279774752 0.3263298312979732 1.0 0.920772021180866 9 P31751 1 |
| Histone modifications 0.5422007605763594 0.955889875991174 0.3391278743767572 1.0 0.920772021180866 7 Q03164 1 |
| Glycosylation and related congenital defects 0.5206582027690094 0.9510185527732938 0.3415949579073789 1.0 0.920772021180866 10 Q9H0U3,Q9Y5P6,Q2TAA5,Q9H3H5 4 |
| Nucleotide excision repair 0.3937281870605305 0.933594606978095 0.3505130482791545 1.0 0.920772021180866 27 P41440 1 |
| Pi3kakt signaling pathway 0.3635981306884244 0.926442954582126 0.3542158299034685 1.0 0.920772021180866 41 P13807,P23588,O00459,P14625,P63151,Q07820,P31751,P49841,P49815,P30154,P42345 11 |
| Breast cancer pathway 0.390155540309579 0.9212166646705884 0.3569373194624976 1.0 0.920772021180866 29 O00459,Q06609,P31751,Q9UJX6 4 |
| Cohesin complex cornelia de lange syndrome 0.4616239316184065 0.9168856042677972 0.3592025882928866 1.0 0.920772021180866 16 Q9NTI5,Q29RF7 2 |
| Micrornas in cardiomyocyte hypertrophy 0.3881229043008115 0.8798879728154599 0.3789200008011466 1.0 0.9411732043239436 22 O00459,Q9P2K5,P31751 3 |
| Melanoma 0.4333279803750123 0.8712753560163661 0.3836038230592389 1.0 0.9411732043239436 18 P31751 1 |
| Energy metabolism 0.4890260407783954 0.8691712577362466 0.3847534658823521 1.0 0.9411732043239436 12 Q9Y478,P49841 2 |
| Map3k1 role in promoting and blocking gonadal determination 0.5646037162366452 0.8681205881112102 0.3853283214050618 1.0 0.9411732043239436 5 P49841,P35222 2 |
| Ranklrank signaling pathway 0.4627558639101348 0.8676285396461089 0.3855977174905789 1.0 0.9411732043239436 15 O00459,P12931,P31751 3 |
| Tryptophan metabolism 0.4553305118009069 0.8257236973106943 0.4089608464372889 1.0 0.9553069772246046 15 O94788,Q15392 2 |
| Copper homeostasis 0.5058786538428834 0.8151898700713266 0.414963635409177 1.0 0.9571526226214728 8 O75880 1 |
| Mitochondrial complex i assembly model oxphos system 0.3783273728951191 0.809112267416111 0.4184505726249579 1.0 0.9571526226214728 25 Q9NPL8,Q9P032,Q8N183,O95299,O43676,Q9Y6M9,P56556,Q96CU9,O96000,Q9Y375 10 |
| Interleukin11 signaling pathway 0.4221091440388809 0.8015642907824192 0.4228050407496218 1.0 0.9582669473708412 18 O00459,Q15418,O75925 3 |
| Regulation of actin cytoskeleton 0.3522596038380869 0.7935754245101901 0.4274426440243069 1.0 0.9582669473708412 40 Q9UQB8,O00459,Q14185,Q9UJX6,Q92888 5 |
| Triacylglyceride synthesis 0.5444393216619677 0.7844657022506204 0.4327668992648641 1.0 0.9595850052779994 5 Q9HCL2 1 |
| Mirna regulation of prostate cancer signaling pathways 0.4879090054798576 0.7590253546899319 0.4478373897841607 1.0 0.977173384454465 9 Q8NCF5,P49841 2 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.492325319904516 0.728067917719262 0.4665720117140468 1.0 0.977173384454465 7 P42345,O00459,P49841,P49815 4 |
| Pancreatic adenocarcinoma pathway 0.364417341048336 0.7110594316495751 0.4770474079700761 1.0 0.9832439596188473 27 Q06609,P31751 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6535947712418296 0.6916027384609271 0.4891868414692084 1.0 0.9832439596188473 3 P49841,P35222 2 |
| Dna mismatch repair 0.370106954974973 0.6708895001418379 0.5022909257381087 1.0 0.993960492692832 21 P41440 1 |
| Nrf2are regulation 0.4697521076428288 0.6493814257405744 0.5160918667005583 1.0 0.993960492692832 8 P49841,P09601 2 |
| Tolllike receptor signaling pathway 0.4200569073109738 0.6303127380946695 0.5284899905025204 1.0 0.993960492692832 15 P31751 1 |
| Nonsmall cell lung cancer 0.3839548486886516 0.6269295834662598 0.5307053942668207 1.0 0.993960492692832 19 P31751 1 |
| Nad metabolism sirtuins and aging 0.537215459036793 0.6264474780421184 0.5310214764321346 1.0 0.993960492692832 4 Q00059 1 |
| Hair follicle development organogenesis part 2 of 3 0.6322444515937234 0.6219587744768387 0.5339689762314346 1.0 0.993960492692832 3 P05556 1 |
| Embryonic stem cell pluripotency pathways 0.4252153744946273 0.6164523695143881 0.5375959986870287 1.0 0.993960492692832 14 O00459,P31751 2 |
| Vitamin d metabolism 0.6302651620255281 0.6156168444711563 0.5381474312943384 1.0 0.993960492692832 3 P38435 1 |
| Glutathione metabolism 0.4704866413500342 0.6128414521518334 0.5399811790704372 1.0 0.993960492692832 6 P00390 1 |
| Cardiac hypertrophic response 0.4302592739014662 0.605080003586474 0.5451258400383705 1.0 0.9960977900247177 13 P49841,P31751 2 |
| Egfr tyrosine kinase inhibitor resistance 0.3784541274451273 0.5929118159112057 0.5532401699223182 1.0 1.0 19 O00459,P49841,P12931,P31751 4 |
| Influence of laminopathies on wnt signaling 0.4343394764925141 0.5917869788755331 0.5539932436657158 1.0 1.0 12 P50402,O60725,P49841,P02545,Q5JTV8 5 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3869527049342363 0.5880261119257632 0.5565147662004224 1.0 1.0 18 Q9BTV4,O94901,P33176,Q8WXH0 4 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4884250910384432 0.5611511902816355 0.5746944737237287 1.0 1.0 5 P12814 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3885034663727181 0.5464769008009458 0.5847381617088143 1.0 1.0 17 O60725,P50402,P49841,P55209 4 |
| Zinc homeostasis 0.6075685903819882 0.5444600791101456 0.5861249124902081 1.0 1.0 3 Q8TAD4 1 |
| Interactions between loxl4 and oxidative stress pathway 0.5071606475716046 0.5202974905343822 0.6028562446862031 1.0 1.0 4 Q9BQ95,Q8TAG9,Q96EB6 3 |
| Hostpathogen interaction of human coronaviruses autophagy 0.5987979712696734 0.5178014975868778 0.6045967733451292 1.0 1.0 3 P42345 1 |
| Thyroid stimulating hormone tsh signaling pathway 0.3351995946886705 0.5061602714916434 0.6127441422323958 1.0 1.0 22 Q15418 1 |
| Alpha 6 beta 4 signaling pathway 0.4259552259579618 0.4981890325384749 0.6183508119482681 1.0 1.0 10 O00459,P12931 2 |
| Praderwilli and angelman syndrome 0.4305667085783528 0.497074121864501 0.6191367827019898 1.0 1.0 9 Q7L576 1 |
| P53 transcriptional gene network 0.4320800321503782 0.4847123764238735 0.6278803860092184 1.0 1.0 8 Q709F0 1 |
| Mitochondrial complex iv assembly 0.4227974184270823 0.4841044407488616 0.628311749871125 1.0 1.0 10 P13073,Q9Y2R0 2 |
| Glioblastoma signaling pathways 0.330537751394296 0.4748645035869001 0.6348835534575987 1.0 1.0 22 P31751 1 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.7373988799004372 0.4738574745870538 0.6356015459632538 1.0 1.0 2 Q8TD30 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.4214828381775147 0.457902756998127 0.6470223060670088 1.0 1.0 9 Q08209,Q8WX92,Q8IXH7 3 |
| Egfegfr signaling pathway 0.293175523635978 0.4527561759610526 0.6507243235211362 1.0 1.0 47 Q15418,P16949,P51812,Q92888 4 |
| Dna damage response only atm dependent 0.3362279153980654 0.4481685893729257 0.6540315299613702 1.0 1.0 21 O00459,P31751 2 |
| Focal adhesion 0.315614086772376 0.4212230080024299 0.6735922449999152 1.0 1.0 37 Q14185 1 |
| Sphingolipid metabolism in senescence 0.3910590480397808 0.3884152872898055 0.697708732948549 1.0 1.0 12 Q06136 1 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3135183222780698 0.3641681028571989 0.7157324842373023 1.0 1.0 22 O00459,P31751,P19022 3 |
| Interactome of polycomb repressive complex 2 prc2 0.5412123947220294 0.3569313499712702 0.7211431995559525 1.0 1.0 3 Q9NYF8 1 |
| Mitochondrial immune response to sarscov2 0.3968301270802762 0.3561414036251425 0.7217346716816464 1.0 1.0 9 Q9Y6M9,Q9Y375,Q9Y276 3 |
| Modulators of tcr signaling and t cell activation 0.3732187680458796 0.3326879065317326 0.7393698792356143 1.0 1.0 13 O96000 1 |
| Nucleotide metabolism 0.3775903508148523 0.3297957074523555 0.7415543310464909 1.0 1.0 12 P00374 1 |
| Wnt signaling pathway 0.3710900246226699 0.3233582396403042 0.7464239520476148 1.0 1.0 13 P49840,Q9BTU6,P49841,P49815,P42345 5 |
| Tcell receptor tcr signaling pathway 0.3314107932529202 0.3190018799651042 0.7497250871986996 1.0 1.0 19 P08670 1 |
| Splicing factor nova regulated synaptic proteins 0.348124880011218 0.2972537625913053 0.7662727791039812 1.0 1.0 16 O14936,Q12955,Q9Y2J2,P19022 4 |
| Genes controlling nephrogenesis 0.4125800469056949 0.2968175740149728 0.7666057876689814 1.0 1.0 5 P05556,Q12948 2 |
| Regulatory circuits of the stat3 signaling pathway 0.3760604641953846 0.2765921254078181 0.7820933119087581 1.0 1.0 9 P12931,P16949 2 |
| Vitamin b12 disorders 0.5051353874883407 0.2712367505056222 0.7862089492046185 1.0 1.0 3 P22033,Q99707 2 |
| Pkcgamma calcium signaling pathway in ataxia 0.6540136901057907 0.269098695262429 0.7878537344446748 1.0 1.0 2 Q15118 1 |
| Chemokine signaling pathway 0.2976066242408517 0.2559716585559085 0.7979727216144106 1.0 1.0 24 O00459,P31751 2 |
| Mapk signaling pathway 0.2906487707829252 0.2548042217152003 0.7988743144212469 1.0 1.0 39 P31751,P51812 2 |
| Fibrin complement receptor 3 signaling pathway 0.3942696979134251 0.2429153581062724 0.8080709678117868 1.0 1.0 5 P31749,P12931,P61586,O15111 4 |
| Dna repair pathways full network 0.2760198684659704 0.2408016941615391 0.8097088165029622 1.0 1.0 57 Q14191,Q9UQ84,P54725,P41440 4 |
| Met in type 1 papillary renal cell carcinoma 0.2904564774111099 0.2255347843350093 0.821563268342699 1.0 1.0 22 O00459,P12931,P31751 3 |
| Lipid metabolism pathway 0.3499050648336256 0.218609517545739 0.8269542381956467 1.0 1.0 12 P31751 1 |
| Serotonin and anxiety 0.6116988176726863 0.1904970683458414 0.848919640247078 1.0 1.0 2 Q08209 1 |
| Apoptosis 0.3329737747226967 0.1859912574495765 0.8524516172547525 1.0 1.0 14 Q07820 1 |
| G13 signaling pathway 0.3140881612241037 0.1707668261681502 0.864407114754514 1.0 1.0 17 O00459,Q92888 2 |
| Heart development 0.3791819154489727 0.1661106690021892 0.8680698581536999 1.0 1.0 4 Q12948 1 |
| Nucleotide excision repair in xeroderma pigmentosum 0.2819438834344378 0.1656386028785699 0.8684413661948787 1.0 1.0 36 P41440 1 |
| Ketone bodies synthesis and degradation 0.3757783312577809 0.1595538826008667 0.8732325098059783 1.0 1.0 4 P55809,P35914,P35610 3 |
| Primary focal segmental glomerulosclerosis fsgs 0.3030937384916037 0.1483069961246911 0.8821004943097561 1.0 1.0 18 P08670,P35579,P46939,P19022 4 |
| Fluoropyrimidine activity 0.3278670571753594 0.1407655071937704 0.8880551929571703 1.0 1.0 12 P00374 1 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.2630044859910113 0.1382003833553581 0.8900820521313471 1.0 1.0 45 P19022,P05198,P84095,Q7L576,Q15418,O00459,P49841,P12931,P51812,P67809 10 |
| Ras signaling 0.2781307625767891 0.1270106722416878 0.8989319517333785 1.0 1.0 30 P31751 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.3200863705448572 0.1158409934659578 0.9077785611077 1.0 1.0 12 P50402,P19022,P12814,P16615,P02545 5 |
| Aryl hydrocarbon receptor pathway wp2873 0.3403924011211489 0.1136953590484895 0.9094792916087892 1.0 1.0 5 Q16543,Q15185,O00170,P12931 4 |
| Il7 signaling pathway 0.3243807767119526 0.1104551345875186 0.9120484294965494 1.0 1.0 9 O00459 1 |
| Bile acids synthesis and enterohepatic circulation 0.544181705040456 0.103205293131301 0.9178000390361274 1.0 1.0 2 P51114 1 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.5441817050404552 0.1032052931313002 0.917800039036128 1.0 1.0 2 P19174 1 |
| Vitamin d receptor pathway 0.3094989200888726 0.1020666015721682 0.9187038106167128 1.0 1.0 14 P09493,P11413,Q96KA5,Q5VV42 4 |
| Onecarbon metabolism and related pathways 0.3104533132218299 0.094854900727425 0.9244300789386526 1.0 1.0 13 P35790,P00390 2 |
| 16p112 distal deletion syndrome 0.3191040984911986 0.0935225973921651 0.9254883982444172 1.0 1.0 7 Q8NCF5 1 |
| Rac1pak1p38mmp2 pathway 0.2782844709174303 0.0934100365352711 0.9255778173793164 1.0 1.0 20 Q06609 1 |
| Bladder cancer 0.3173685606077958 0.091977647288604 0.926715799176734 1.0 1.0 9 O00459 1 |
| Id signaling pathway 0.5146235220908589 0.0786937136837537 0.9372762457285712 1.0 1.0 2 P24941 1 |
| Molybdenum cofactor moco biosynthesis 0.508400746733046 0.0744651093362235 0.9406403027776782 1.0 1.0 2 Q9NQX3 1 |
| 22q112 copy number variation syndrome 0.2672523579217682 0.0707403661159527 0.9436043937781272 1.0 1.0 35 O00192,P21964,Q9UQ13,Q92890,Q9NQC3,O75419,O94788 7 |
| Hepatitis b infection 0.2646602969735779 0.0677927214143283 0.9459506379039048 1.0 1.0 26 P31751 1 |
| Prion disease pathway 0.3046629697677175 0.0633423549059643 0.9494938891220208 1.0 1.0 6 P14625 1 |
| Malignant pleural mesothelioma 0.2660897965882497 0.0627385833216554 0.9499746728488356 1.0 1.0 69 Q9Y478,P19022,Q15418,P49841,Q07820,P31751,P51812 7 |
| Dna damage response 0.264494908231918 0.062726046934781 0.9499846557759096 1.0 1.0 27 P41440 1 |
| Translation factors 0.2644630922892355 0.062252314084235 0.9503619026251002 1.0 1.0 37 O75153 1 |
| Neovascularisation processes 0.4576851275669075 0.0500762131368685 0.960061655117912 1.0 1.0 2 P28482 1 |
| Mammary gland development pathway embryonic development stage 1 of 4 0.4576851275668966 0.0500762131368649 0.9600616551179147 1.0 1.0 2 P05556 1 |
| Mirna regulation of dna damage response 0.2625735965382758 0.0497952584693113 0.9602855451909692 1.0 1.0 28 P41440 1 |
| Amyotrophic lateral sclerosis als 0.296399869274048 0.0436063872881153 0.9652181602229328 1.0 1.0 10 P07197,P07196 2 |
| Wnt signaling in kidney disease 0.4212818917237064 0.0410704033404267 0.9672397694004048 1.0 1.0 2 P35222 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.4178593652769228 0.0404847491210235 0.967706665512026 1.0 1.0 2 O94826 1 |
| Pi3kaktmtor vitd3 signaling 0.293774742963773 0.0403259508706912 0.9678332647994136 1.0 1.0 7 P49841,P42345 2 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.2864964403676818 0.0337025530521558 0.9731143430894108 1.0 1.0 14 Q9UJX6,P49841 2 |
| Oligodendrocyte specification and differentiation leading to myelin components for cns 0.2968263845675087 0.0335673392218693 0.973222167108494 1.0 1.0 2 Q99640 1 |
| Phosphoinositides metabolism 0.2854874104542786 0.0290384068115625 0.9768339592936472 1.0 1.0 6 Q9NTJ5,Q99570,Q01968 3 |
| Caloric restriction and aging 0.2749922142634721 0.0206490446211349 0.9835256168427248 1.0 1.0 5 P31749,Q96EB6,P42345,P04637 4 |
| Head and neck squamous cell carcinoma 0.2634444769689386 0.0037928966758572 0.9969737135576736 1.0 1.0 18 P31751 1 |
|
|
